1
Return

Ciltacabtagene autoleucel heralds the arrival of fixed-duration therapies in myeloma

delete2026-07-14
delete0
PRE
AI
G
Ghulam Rehman Mohyuddin *
E
Edward R. Scheffer Cliff
R
Rajshekhar Chakraborty
DOI:10.1038/s41571-026-01185-4delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En

Journal

Nature Reviews Clinical Oncology cover
Nature Reviews Clinical Oncology
IF:
82.2
Papers:
2.3K
Citations:
3.3W

Organization

U
University of Utah
Scholars:
2.9W
Papers: 2.2W
Citations: 4.6W
C
columbia university irving medical center
Scholars:
443
Papers: 134
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers